期刊文献+

移植细胞的种类及其有效性和安全性——细胞移植治疗连载之二 被引量:4

The Types,Safety and Efficacity of the Transplanted Cells
原文传递
导出
摘要 用于移植治疗的细胞主要有肝细胞、胰岛细胞、树突状细胞、细胞因子诱导的杀伤细胞、淋巴因子激活的杀伤细胞、胚胎干细胞、造血干细胞、间充质干细胞等,每种细胞都有不同的生物学特性。在临床应用前,要严格按照国家食品药品监督管理局的有关规定,研究特定细胞制剂的生物学特性、药理学、毒理学等,进行动物和临床试验,确定适应症、禁忌症,评估有效性和安全性。正式获得国家食品药品监督管理局许可后,再进行相关临床研究和应用。 The cells used for cell transplantation therapy mainly consist of hepatoeyte, islet cells, dendritic cells, cytokine-induced killer cells, lymphokine activated killer cells, embryonic stem cells, hemopoietic stem cells, and mesenehymal stem cells, etc. Every cell kind has different biological characteristics. Before clinic application, according to the related documents of State Food and Drug Administration, the specific cell agent is studied on its biological characteristics, pharmacology, and toxicology, etc. Animal experiments and clinical tests are carried on to assure its indications and contraindieations for assessment of safety and efficacity. After a license has been obtained from State Food and Drug Administration, the related clinical researches and applications can be carried on.
作者 王佃亮
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2013年第9期119-125,共7页 China Biotechnology
关键词 细胞移植治疗 体细胞 干细胞 Cell transplantation therapy Somatic cell Stem cell
  • 相关文献

参考文献17

  • 1Liau B, Zhang D, Bursac N. Functional cardiac tissue engineering. Regen Med, 2012,7 (2) : 187-206.
  • 2Lipinski M J, Biondi-Zoccai G G, Abbate A, et al. hnpact of intracoronary cell cherapy on left ventricular function in the setting of acute myocardial infarction : A collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coil Cardiol, 2007,50 : 1761.
  • 3Silva E A, Kim E S, Kong H J, et al. Material-based deployment enhances efficacy of endothelial progenitor cells. PNAS, 2008, 105 : 14347-14352.
  • 4Li X D, Xu B, Wu J, et al. Review of chinese clinical trials on CIK cell treatment for malignancies. Clin Transl Oncol,2012,14 (2) :102-108.
  • 5Nehls V, Herrmann R, Huhnken M. Guided migration as a novel mechanism of capillary network remodeling is regulated by basic fibroblast growth factor. Histochem Cell Biol, 1998,109 : 319- 329.
  • 6Simmoneau G, Robbins I M, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coil Cardiol, 2009,54 : S43-54.
  • 7Lei Z, Yongda L, Jun M, et al. Culture and neural differentiation of rat bone marrow mesenchymal stem cells in vitro. Cell Biol Int, 2007,31:916-923.
  • 8Russ H A, Efral S. Development of human insulin-producing cells for cell therapy of diabetes. Pediatr Endocrinol Rev, 2011,9 (2) :590-597.
  • 9Coopman K. Large-scale compatible methods for the preservation of human embryonic stem cells : current perspectives. Biotechnol Prog, 2011, 27 ( 6 ) : 1511 - 1521.
  • 10Meyer G P,Wollert K C, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration ) trial. Circulation, 2006,113 : 1287.

同被引文献21

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部